Skip to main content

Center Store

  • Walgreens Boots Alliance reduces stake in China's pharmacy wholesaler

    It has been announced that Walgreens Boots Alliance will be reducing its stake in Guangzhou Pharmaceuticals Corporation, a pharmaceutical wholesaling joint venture in China. This announcement comes after the Deerfield, Ill.-based company announced plans earlier this year their plans to take a 40% stake in Sinopharm Holding GuoDa Drugstores.

  • Teva announces generic Reyataz capsules

    Teva has introduced its generic of Reyataz (atazanavir) capsules within the United States, the company announced. The drug is indicated to be used in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients six years old and older who weigh at least 15 kg.

  • Texas once again tops Walgreens Flu Index activity

    Walgreens has released yet another update in its Flu Index activity. For a third straight week, Texas holds the top spot in an increase in incidences of influenza according to the newly released data for the week ending Dec. 23.

  • My/Mo Mochi Ice Cream expands to non-dairy, vegan offerings

    My/Mo Mochi Ice Cream will be hitting select retail stores shelves with a new line of non-dairy and vegan products. The Los Angeles-based company's latest launch, My/Mo Mochi Cashew Cream Frozen Dessert items will include the flavors: strawberry, vanilla, chocolate and salted caramel.

    The product is made with a scoop of frozen cashew cream, wrapped in rice dough and clocks in at just 100 calories per ball. Launching these new vegan and non-dairy offerings will allow a new set of consumers to enjoy this snack, the company said.

  • Amneal’s generic Renvela comes to market

    Amneal Pharmaceuticals has launched sevelamer carbonate tablets, 800 mg, in 270-count bottles. This generic from the Bridgewater, N.J.-based company is an AB-rated therapeutic equivalent to Renvela.

    Amneal also launched five other products in addition to sevelamer carbonate:

  • Amazon’s private-label products pull in nearly $450M in 2017

    Private label has become big business for Amazon in 2017 — and momentum continues to grow.

    The online giant used 2017 to refine its private-label strategy — a move that helped the company launch over 30 new brand names across highly competitive categories. As a whole, these private-label brands generated roughly $450 million in sales in this year, according to “Amazon Private Brands: Year-End Review,” a study from One Click Retail.

  • Perfect365: Celebrity impact on emerging beauty trends

    As the season's change, so do the trends in just about every industry – including beauty.

X
This ad will auto-close in 10 seconds